Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 248060, 8 pages
http://dx.doi.org/10.1155/2015/248060
Research Article

Genetic Polymorphisms of Multidrug Resistance Gene-1 (MDR1/ABCB1) and Glutathione S-Transferase Gene and the Risk of Inflammatory Bowel Disease among Moroccan Patients

1Laboratory of Genetics and Molecular Pathologies, Faculty of Medicine and Pharmacy of Casablanca, Casablanca, Morocco
2Gastroenterology Department, CHU Ibn Rochd, Casablanca, Morocco

Received 29 May 2015; Revised 6 September 2015; Accepted 8 September 2015

Academic Editor: Tânia Silvia Fröde

Copyright © 2015 Nezha Senhaji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. M’Koma, “Inflammatory bowel disease: an expanding global health problem,” Clinical Medicine Insights: Gastroenterology, vol. 6, pp. 33–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Low, A. Mizoguchi, and E. Mizoguchi, “DNA methylation in inflammatory bowel disease and beyond,” World Journal of Gastroenterology, vol. 19, no. 32, pp. 5238–5249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Frolkis, L. A. Dieleman, H. W. Barkema et al., “Environment and the inflammatory bowel diseases,” Canadian Journal of Gastroenterology, vol. 27, no. 3, pp. e18–e24, 2013. View at Google Scholar · View at Scopus
  4. C. Ekhart, S. Rodenhuis, P. H. M. Smits, J. H. Beijnen, and A. D. R. Huitema, “An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment,” Cancer Treatment Reviews, vol. 35, no. 1, pp. 18–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Ueda, I. Pastan, and M. M. Gottesman, “Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene,” The Journal of Biological Chemistry, vol. 262, no. 36, pp. 17432–17436, 1987. View at Google Scholar · View at Scopus
  6. F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham, “Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 21, pp. 7735–7738, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Marzolini, E. Paus, T. Buclin, and R. B. Kim, “Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance,” Clinical Pharmacology and Therapeutics, vol. 75, no. 1, pp. 13–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. F. Fromm, “Genetically determined differences in P-glycoprotein function: implications for disease risk,” Toxicology, vol. 181-182, pp. 299–303, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M. Onnie, S. A. Fisher, R. Pattni et al., “Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study,” Inflammatory Bowel Diseases, vol. 12, no. 4, pp. 263–271, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Schwab, E. Schaeffeler, C. Marx et al., “Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis,” Gastroenterology, vol. 124, no. 1, pp. 26–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gazouli, P. Zacharatos, V. Gorgoulis, G. Mantzaris, E. Papalambros, and I. Ikonomopoulos, “The C3435T MDR1 gene polymorphism is not associated with susceptibility for ulcerative colitis in Greek population,” Gastroenterology, vol. 126, no. 1, pp. 367–369, 2004. View at Google Scholar · View at Scopus
  12. A. Rezaie, R. D. Parker, and M. Abdollahi, “Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?” Digestive Diseases and Sciences, vol. 52, no. 9, pp. 2015–2021, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. D. Hayes and L. I. McLellan, “Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress,” Free Radical Research, vol. 31, no. 4, pp. 273–300, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. W. R. Pearson, W. R. Vorachek, S.-J. Xu et al., “Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13,” The American Journal of Human Genetics, vol. 53, no. 1, pp. 220–233, 1993. View at Google Scholar · View at Scopus
  15. G. Webb, V. Vaska, M. Coggan, and P. Board, “Chromosomal localization of the gene for the human Theta class glutathione transferase (GSTT1),” Genomics, vol. 33, no. 1, pp. 121–123, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Hallier, T. Langhof, D. Dannappel et al., “Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes,” Archives of Toxicology, vol. 67, no. 3, pp. 173–178, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Sharma, S. Jain, A. Verma et al., “Gene environment interaction in urinary bladder cancer with special reference to organochlorine pesticide: a case control study,” Cancer Biomarkers, vol. 13, no. 4, pp. 243–251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Ma, L. Zhuang, B. Han, and B. Tang, “Association between glutathione S-transferase T1 null genotype and gastric cancer risk: a meta-analysis of 48 studies,” PLoS ONE, vol. 8, no. 4, Article ID e60833, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Dong, Y. Tian, S. Chen, X. Xu, J. Zheng, and T. Li, “Glutathione S-transferase T1 null genotype is associated with oral cancer susceptibility in Asian populations,” Tumor Biology, vol. 34, no. 3, pp. 1753–1757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Bhat, A. Bhat, A. Wani et al., “Polymorphic variation in glutathione-S-transferase genes and risk of chronic myeloid leukaemia in the Kashmiri population,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 1, pp. 69–73, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Karban, N. Krivoy, H. Elkin et al., “Non-jewish Israeli IBD patients have significantly higher glutathione S-transferase GSTT1-null frequency,” Digestive Diseases and Sciences, vol. 56, no. 7, pp. 2081–2087, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Duncan, C. Swanx, J. Green et al., “Susceptibility to ulcerative colitis and Crohn’s disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes,” Clinica Chimica Acta, vol. 240, no. 1, pp. 53–61, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. R. D. Mittal, P. K. Manchanda, H. K. Bid, and U. C. Ghoshal, “Analysis of polymorphisms of tumor necrosis factor-α and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India,” Journal of Gastroenterology and Hepatology, vol. 22, no. 6, pp. 920–924, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Malchow, K. Ewe, J. W. Brandes et al., “European Cooperative Crohn’s Disease Study (ECCDS): results of drug treatment,” Gastroenterology, vol. 86, no. 2, pp. 249–266, 1984. View at Google Scholar · View at Scopus
  25. N. Senhaji, B. Diakité, N. Serbati, Y. Zaid, W. Badre, and S. Nadifi, “Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: new data and a meta-analysis,” BMC Gastroenterology, vol. 14, article 206, 2014. View at Publisher · View at Google Scholar
  26. Y. Kassogue, H. Dehbi, S. Nassereddine, M. Quachouh, and S. Nadifi, “Genotype variability and haplotype frequency of MDR1 (ABCB1) gene polymorphism in Morocco,” DNA and Cell Biology, vol. 32, no. 10, pp. 582–588, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Yaya, D. Hind, Q. Meryem, Q. Asma, B. Said, and N. Sellama, “Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia,” Tumor Biology, vol. 35, no. 11, pp. 10969–10975, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Kassogue, M. Quachouh, H. Dehbi, A. Quessar, S. Benchekroun, and S. Nadifi, “Effect of interaction of glutathione S-transferases (T1 and M1) on the hematologic and cytogenetic responses in chronic myeloid leukemia patients treated with imatinib,” Medical Oncology, vol. 31, article 47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Fischer, P. L. Lakatos, L. Lakatos et al., “ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases,” Scandinavian Journal of Gastroenterology, vol. 42, no. 6, pp. 726–733, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Huebner, B. L. Browning, I. Petermann et al., “Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis,” Inflammatory Bowel Diseases, vol. 15, no. 12, pp. 1784–1793, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Wang, X. Guo, S. Yu et al., “MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysis,” Molecular Biology Reports, vol. 41, no. 4, pp. 2679–2685, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Brinar, S. Cukovic-Cavka, N. Bozina et al., “MDR1 polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients,” BMC Gastroenterology, vol. 13, no. 1, article 57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Juyal, V. Midha, D. Amre, A. Sood, E. Seidman, and B. K. Thelma, “Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians,” Pharmacogenetics and Genomics, vol. 19, no. 1, pp. 77–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Hoffmeyer, O. Burk, O. von Richter et al., “Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3473–3478, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Vivona, C. T. Bueno, L. T. Lima et al., “ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib,” Blood Cells, Molecules, & Diseases, vol. 48, no. 2, pp. 132–136, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. Yang, B. Chen, Q. Zhang et al., “Contribution of MDR1 gene polymorphisms on IBD predisposition and response to glucocorticoids in IBD in a Chinese population,” Journal of Digestive Diseases, vol. 16, no. 1, pp. 22–30, 2015. View at Publisher · View at Google Scholar
  37. M. J. Bonyadi, S. M. Gerami, M. H. Somi, and M. Khoshbaten, “Effect of the C3435T polymorphism of the multidrug resistance 1 gene on the severity of inflammatory bowel disease in Iranian Azeri Turks,” Saudi Journal of Gastroenterology, vol. 19, no. 4, pp. 172–176, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Dudarewicz, M. Barańska, M. Rychlik-Sych, R. Trzciński, A. Dziki, and J. Skreţkowicz, “C3435T polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in a Polish population,” Pharmacological Reports, vol. 64, no. 2, pp. 343–350, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Ardizzone, G. Maconi, V. Bianchi et al., “Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 13, no. 5, pp. 516–523, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. T. H. Karlsen, J. Hampe, K. Wiencke et al., “Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis,” The American Journal of Gastroenterology, vol. 102, no. 1, pp. 115–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Fiedler, C. Büning, W. Reuter et al., “Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn’s disease,” European Journal of Clinical Pharmacology, vol. 63, no. 10, pp. 917–925, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. L. E. Oostenbrug, G. Dijkstra, I. M. Nolte et al., “Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease,” Scandinavian Journal of Gastroenterology, vol. 41, no. 10, pp. 1174–1182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. G.-T. Ho, N. Soranzo, E. R. Nimmo, A. Tenesa, D. B. Goldstein, and J. Satsangi, “ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach,” Human Molecular Genetics, vol. 15, no. 5, pp. 797–805, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Urcelay, J. L. Mendoza, M. C. Martín et al., “MDR1 gene: susceptibility in Spanish Crohn’s disease and ulcerative colitis patients,” Inflammatory Bowel Diseases, vol. 12, no. 1, pp. 33–37, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. O. Palmieri, A. Latiano, R. Valvano et al., “Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients,” Alimentary Pharmacology & Therapeutics, vol. 22, no. 11-12, pp. 1129–1138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. G.-T. Ho, E. R. Nimmo, A. Tenesa et al., “Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis,” Gastroenterology, vol. 128, no. 2, pp. 288–296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Glas, H.-P. Török, U. Schiemann, and C. Folwaczny, “MDR1 gene polymorphism in ulcerative colitis,” Gastroenterology, vol. 126, no. 1, article 367, 2004. View at Google Scholar · View at Scopus